On December 6, 2021, vTv Therapeutics Inc. announced a reduction in the Company’s workforce affecting approximately 65% of its employees and the Company expects to incur severance costs of approximately $1.5 million. In addition, the Company expects these actions to result in annualized cost savings of approximately $2.8 million. Some of these reductions may be offset by higher costs for outsourced services which cannot be quantified at this time.